A study to observe the trend of SARS-CoV-2, Dengue and Chikungunya infection transmission in the general population.
Not Applicable
- Conditions
- Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhereHealth Condition 2: A90- Dengue fever [classical dengue]Health Condition 3: B978- Other viral agents as the cause ofdiseases classified elsewhere
- Registration Number
- CTRI/2020/11/028968
- Lead Sponsor
- ational Biopharma Mission NBM Biotechnology Industry Research Assistance Council BIRAC
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Survey will be carried out in individuals above 2 years of age and all individuals currently residing and likely to stay till the end of study (1 year) in the study area will be considered eligible for inclusion.
Exclusion Criteria
Consent refusal
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1.Determining the burden of COVID 19 infection at the community level and monitor the trends in transmission of SARS-CoV-2 infection. <br/ ><br>2.Risk factors for infection can be identified which might inform future control strategies.Timepoint: Outcome 1: 12 months <br/ ><br>Outcome 2: 12 months
- Secondary Outcome Measures
Name Time Method The serial surveys in the same set of individuals will help in measuring the antibody levels over a period of time and understand the proportion of individuals who are able to mount a neutralisation response and the duration for which immunity lasts after infection.Timepoint: 12 months